Researchers identify gene responsible for rare childhood disease

Jul 24, 2008

The chromosomal abnormality that causes a rare, but often fatal, disorder that affects infants has been identified by researchers at the University of California, San Diego School of Medicine, who happened to treat two young children with the disease in San Diego – two of perhaps a dozen children in the entire country diagnosed with the disorder.

Congenital Tufting Enteropathy (CTE) is a rare, congenital disorder that causes changes in the intestines of children that lead to severe diarrhea, the inability to consume food or absorb nutrition, and subsequent growth failure. Children with CTE are dependent on receiving nutrition through an IV (or catheter in a vein), which can result in many medical problems and even early death. Despite its grave complications, there has been little understanding about what causes this devastating "orphan" disease which,

Two of those children live in the San Diego area where they were being treated at Rady Children's Hospital. But it was a second strange coincidence that led the study's principal investigator Mamata Sivagnanam, M.D., assistant professor of clinical pediatrics in the Division of Pediatric Gastroenterology, Hepatology and Nutrition at UCSD's School of Medicine and Rady Children's Hospital in San Diego, to discover the gene that is altered in patients with CTE.

The discovery will be published as a cover story of the August issue of the journal Gastroenterology, and is currently available on line.

Sivagnanam and her colleagues were treating a young infant with severe diarrhea in the neonatal intensive care unit at Rady Children's Hospital and diagnosed him with CTE. At the same time, they were treating this rare disorder in another child, who was 1-1/2 years old at the time, and noticed that they both had the same, uncommon last name.

"It turned out that these two children were what is called double second cousins," Sivagnanam said, meaning that the two mothers are first cousins, and so are the two fathers – sharing a common set of grandparents. "We suspected that this was a heritable disease, but these two families – unknown to one another – each had a child with CTE. This unique familial relationship enabled us to isolate the chromosome mutated in the disorder."

Using genetic technology that can determine small variations in the genetic code within a person's DNA sequence known as single nucleotide polymorphisms (or SNPs, pronounced "snips"), the researchers determined that mutation of a molecule known as the Epithelial Cell Adhesion Molecule or EpCAM is the cause of CTE.

"We hope that this information will allow us to not only understand what causes this disease, but eventually lead to further advances in its diagnosis and treatment," Sivagnanam said. "By understanding the role of EpCAM in the intestine, it may also lead to better understanding of diseases such as colon cancer and inflammatory bowel disease."

Source: University of California - San Diego

Explore further: Clues to genetics of congenital heart defects emerge from Down syndrome study

add to favorites email to friend print save as pdf

Related Stories

Video game teaches kids how to code

Sep 10, 2014

Computer scientists at the University of California, San Diego have successfully funded on Kickstarter a new and improved version of CodeSpells, a first-person player game they developed that teaches players ...

Dolphins and whales experience pleasure

Aug 13, 2014

Sam Ridgway has spent most of his life learning about dolphins and whales. Over his five-decade career he has asked these cetaceans various questions, including how deep they can dive and how depth affects ...

The playground of neural engineering

May 08, 2014

A game player uses Thalia, a wearable interactive system, and then smiles in order to keep a unicorn in flight as it jumps through rainbows.

Recommended for you

Right environment could improve stem cell therapies

Oct 23, 2014

Stem cell therapies are being hailed as a potential cure for many major health conditions, but there is much still to learn about the highly complex environments needed to optimise these therapies, according to researchers ...

User comments : 0